Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With Metastatic Castrate Resistant Prostate Cancer
Latest Information Update: 31 Jan 2024
At a glance
- Drugs Dexamethasone (Primary) ; Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- Acronyms TRANCE
- 23 Jan 2024 Planned End Date changed from 15 Dec 2022 to 30 Jul 2024.
- 23 Jan 2024 Status changed from recruiting to active, no longer recruiting.
- 13 Apr 2022 Planned End Date changed from 15 Feb 2022 to 15 Dec 2022.